Cargando…

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

As SARS-CoV-2 variants continue to emerge globally, a major challenge for COVID-19 vaccination is the generation of a durable antibody response with cross-neutralizing activity against both current and newly emerging viral variants. Cross-neutralizing activity against major variants of concern (B.1....

Descripción completa

Detalles Bibliográficos
Autores principales:	Dupont, Liane, Snell, Luke B., Graham, Carl, Seow, Jeffrey, Merrick, Blair, Lechmere, Thomas, Hallett, Sadie R., Charalampous, Themoula, Alcolea-Medina, Adela, Huettner, Isabella, Maguire, Thomas J. A., Acors, Sam, Almeida, Nathalia, Cox, Daniel, Dickenson, Ruth E., Galao, Rui Pedro, Jimenez-Guardeño, Jose M., Kouphou, Neophytos, Lista, Marie Jose, Pickering, Suzanne, Ortega-Prieto, Ana Maria, Wilson, Harry, Winstone, Helena, Fairhead, Cassandra, Su, Jia, Nebbia, Gaia, Batra, Rahul, Neil, Stuart, Shankar-Hari, Manu, Edgeworth, Jonathan D., Malim, Michael H., Doores, Katie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202432/ https://www.ncbi.nlm.nih.gov/pubmed/34127977 http://dx.doi.org/10.1101/2021.06.07.21258351

Ejemplares similares

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
por: Dupont, Liane, et al.
Publicado: (2021)

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
por: Lechmere, Thomas, et al.
Publicado: (2022)

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
por: Graham, Carl, et al.
Publicado: (2021)

SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition
por: Snell, Luke B, et al.
Publicado: (2022)

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
por: Graham, Carl, et al.
Publicado: (2021)

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave
por: Sweeney, Nicola, et al.
Publicado: (2021)

Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London
por: Snell, Luke B, et al.
Publicado: (2022)

Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study
por: Pickering, Suzanne, et al.
Publicado: (2021)

Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission
por: Snell, Luke B., et al.
Publicado: (2022)

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants
por: Snell, Luke B, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
por: Seow, Jeffrey, et al.
Publicado: (2022)

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
por: Seow, Jeffrey, et al.
Publicado: (2023)

Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
por: Pickering, Suzanne, et al.
Publicado: (2020)

Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillance
por: Williams, Tom G. S., et al.
Publicado: (2023)

Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Snell, Luke B, et al.
Publicado: (2022)

Immunoproteasome activation enables human TRIM5α restriction of HIV-1
por: Jimenez-Guardeño, Jose M., et al.
Publicado: (2019)

A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
por: Seow, Jeffrey, et al.
Publicado: (2022)

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
por: Graham, Carl, et al.
Publicado: (2022)

TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
por: Khan, Hataf, et al.
Publicado: (2021)

Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
por: Wells, Philippa M., et al.
Publicado: (2020)

Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals
por: Kurshan, Ashwini, et al.
Publicado: (2023)

ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition—implications for COVID-19
por: El-Sayed Moustafa, Julia S., et al.
Publicado: (2022)

Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome
por: Shaw, Andrew M., et al.
Publicado: (2020)

The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction
por: Betancor, Gilberto, et al.
Publicado: (2019)

Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection
por: Goujon, Caroline, et al.
Publicado: (2013)

Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction
por: Dicks, Matthew D. J., et al.
Publicado: (2018)

The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2
por: Winstone, Helena, et al.
Publicado: (2021)

Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
por: Skelton, Jessica Katy, et al.
Publicado: (2019)

Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19
por: Merrick, B., et al.
Publicado: (2021)

Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units
por: Charalampous, Themoula, et al.
Publicado: (2021)

SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
por: Stirrup, Oliver, et al.
Publicado: (2021)

Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
por: Lista, Maria Jose, et al.
Publicado: (2021)

The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance
por: Lista, Maria Jose, et al.
Publicado: (2022)

Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2
por: Dicks, Matthew D.J., et al.
Publicado: (2022)

Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies
por: Cheetham, Nathan J, et al.
Publicado: (2023)

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes
por: Abdul-Jawad, Sultan, et al.
Publicado: (2022)

MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation
por: Betancor, Gilberto, et al.
Publicado: (2022)

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
por: Fielding, Ceri Alan, et al.
Publicado: (2022)

Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
por: Lista, Maria Jose, et al.
Publicado: (2021)

Low Frequency of T Cell and Antibody Responses to Vaccination Against Sars-Cov-2 in Patients Post Allogeneic Stem Cell Transplantation in Comparison with Chronic Myeloid Malignancy Patients
por: Harrington, Patrick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0psclm37fboov03bm8386frjds